Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 4
2012 4
2013 9
2014 5
2015 2
2016 2
2017 4
2018 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Nicotinic acid: clinical considerations.
Kei A, Elisaf MS. Kei A, et al. Expert Opin Drug Saf. 2012 Jul;11(4):551-64. doi: 10.1517/14740338.2012.682981. Epub 2012 May 7. Expert Opin Drug Saf. 2012. PMID: 22564238 Review.
Emerging drugs for hyperlipidaemia: an update.
Florentin M, Kostapanos MS, Kei A, Elisaf MS. Florentin M, et al. Among authors: kei a. Expert Opin Emerg Drugs. 2014 Dec;19(4):471-88. doi: 10.1517/14728214.2014.976553. Epub 2014 Oct 30. Expert Opin Emerg Drugs. 2014. PMID: 25356785 Review.
Review: Antiplatelet drugs: what comes next?
Kei AA, Florentin M, Mikhailidis DP, Elisaf MS, Liberopoulos EN. Kei AA, et al. Clin Appl Thromb Hemost. 2011 Feb;17(1):9-26. doi: 10.1177/1076029610385222. Epub 2010 Nov 15. Clin Appl Thromb Hemost. 2011. PMID: 21078606 Free article. Review.
What restricts the clinical use of nicotinic acid?
Kei A, Liberopoulos EN, Elisaf MS. Kei A, et al. Curr Vasc Pharmacol. 2011 Jul 1;9(4):521-30. doi: 10.2174/157016111796197215. Curr Vasc Pharmacol. 2011. PMID: 21314634 Review.
29 results